ANN ARBOR, Mich.--(BUSINESS WIRE)--KAI Research, Inc., a wholly owned subsidiary of Altarum Institute, will highlight its latest work around clinical trials and pharmacovigilance at the upcoming Drug Information Association (DIA) Conference, June 14–18, in Washington, DC.
KAI is a full-service contract research organization (CRO) helping pharmaceutical, academic, and federal clients bring innovative drug treatments and interventions to market since 1986.
KAI has supported several clients for multiple decades and coordinated hundreds of clinical trials and epidemiological studies in a wide variety of therapeutic areas with a strong focus in neurology, musculoskeletal conditions, mental health, and infectious disease.
KAI will also debut its new branding efforts and tagline “Right Science, Right Patients, Right Data” at Booth #2740 and throughout the conference. Stop by for your chance to win a new Apple watch.
“This is a great time for KAI and our clients,” said Katherine Dimeo, president of KAI. “Our work and our clients have never been more innovative. We look forward to seeing what comes next.”
For more information, please visit KAI Research or contact Patti Shugarts at pshugarts@kai-research.com.
Altarum Institute (www.altarum.org) integrates objective research and client-centered consulting skills to deliver comprehensive, systems-based solutions that improve health and health care. Altarum employs more than 400 individuals and is headquartered in Ann Arbor, MI, with additional offices in the Washington, DC, area; Portland, Maine; and San Antonio, Texas.
